tiprankstipranks
Advertisement
Advertisement

VNDA Stock Latest News

Vanda Advances NEREUS Launch With Direct-to-Consumer Strategy
Company AnnouncementsVanda Advances NEREUS Launch With Direct-to-Consumer Strategy
20d ago
8K
VNDA
Vanda Pharmaceuticals initiated with a Buy at Truist
PremiumThe Fly
Vanda Pharmaceuticals initiated with a Buy at Truist
25d ago
VNDA
AnaptysBio provides update on potential spin-off of biopharma operations
PremiumThe Fly
AnaptysBio provides update on potential spin-off of biopharma operations
27d ago
GSK
ANAB
Vanda Pharmaceuticals: FDA grants hearing to review sNDA for Hetlioz
PremiumThe Fly
Vanda Pharmaceuticals: FDA grants hearing to review sNDA for Hetlioz
27d ago
VNDA
Vanda Pharmaceuticals: Limited Downside, Pipeline-Driven Upside Supports $24 Target Price
PremiumRatings
Vanda Pharmaceuticals: Limited Downside, Pipeline-Driven Upside Supports $24 Target Price
28d ago
VNDA
Vanda Pharmaceuticals price target raised to $17 from $14 at B. Riley
PremiumThe FlyVanda Pharmaceuticals price target raised to $17 from $14 at B. Riley
1M ago
VNDA
Vanda announces FDA accepted BLA for imsidolimab
Premium
The Fly
Vanda announces FDA accepted BLA for imsidolimab
1M ago
VNDA
Midday Fly By: Trump ups worldwide tariff to 15%, Gilead buying Arcellx
Premium
The Fly
Midday Fly By: Trump ups worldwide tariff to 15%, Gilead buying Arcellx
1M ago
D
DE
Unusually active option classes on open February 23rd
PremiumThe Fly
Unusually active option classes on open February 23rd
1M ago
FRO
SLS
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
1M ago
LYG
OWL
Vanda Wins FDA Approval for Bysanti Antipsychotic Therapy
PremiumCompany Announcements
Vanda Wins FDA Approval for Bysanti Antipsychotic Therapy
1M ago
8K
VNDA
Vanda Pharmaceuticals price target raised to $24 from $22 at H.C. Wainwright
PremiumThe Fly
Vanda Pharmaceuticals price target raised to $24 from $22 at H.C. Wainwright
1M ago
VNDA
Vanda trading resumes
PremiumThe FlyVanda trading resumes
1M ago
VNDA
Vanda Pharmaceuticals announces FDA approval of Bysanti tablets
Premium
The Fly
Vanda Pharmaceuticals announces FDA approval of Bysanti tablets
1M ago
VNDA
Vanda trading halted, news pending
Premium
The Fly
Vanda trading halted, news pending
1M ago
VNDA
Vanda Board Approves 2025 Bonuses and 2026 Compensation
PremiumCompany Announcements
Vanda Board Approves 2025 Bonuses and 2026 Compensation
1M ago
8K
VNDA
FDA Calendar: Vanda Stock (VNDA) Shows 125% Upside with Bysanti Decision on Deck
PremiumMarket News
FDA Calendar: Vanda Stock (VNDA) Shows 125% Upside with Bysanti Decision on Deck
1M ago
VNDA
Regulatory Hurdles Cloud Vanda Pharmaceuticals’ Prospects for Bysanti and Imsidolimab FDA Approvals
PremiumCompany Announcements
Regulatory Hurdles Cloud Vanda Pharmaceuticals’ Prospects for Bysanti and Imsidolimab FDA Approvals
2M ago
VNDA
Vanda Pharmaceuticals Balances Growth With Rising Risks
PremiumCompany Announcements
Vanda Pharmaceuticals Balances Growth With Rising Risks
2M ago
VNDA
Vanda Pharmaceuticals files $200M mixed securities shelf
PremiumThe FlyVanda Pharmaceuticals files $200M mixed securities shelf
2M ago
VNDA
Vanda Pharmaceuticals reports Q4 EPS ($2.39) vs. (8c) last year
Premium
The Fly
Vanda Pharmaceuticals reports Q4 EPS ($2.39) vs. (8c) last year
2M ago
VNDA
Vanda Pharmaceuticals sees FY26 revenue $230M-$260M, consensus $271.27M
Premium
The Fly
Vanda Pharmaceuticals sees FY26 revenue $230M-$260M, consensus $271.27M
2M ago
VNDA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >